JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

简称 J ENZYM INHIB MED CH ·ENGLAND ·出版周期 Bimonthly ·年均收录 317 篇

5.4

最新影响因子

36.20%

自引率

容易

投稿难度

偏慢,4-8周

审稿周期

期刊简介

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY是一本国际学术期刊，ISSN号为1475-6366，由英国出版商Taylor & Francis出版，出版地为英国，出版周期为双月刊。该期刊的影响因子近年来稳步上升，2022年影响因子为5.6，属于SCI收录期刊，中科院分区为医学大类3区。期刊采用混合开放获取（OA）模式，部分文章可免费获取。该期刊专注于酶抑制与药物化学领域的研究，发文特点包括酶抑制剂的设计、合成、机理研究及其在药物开发中的应用，涵盖抗肿瘤、抗感染、抗炎和神经退行性疾病等多个研究方向。期刊质量较高，审稿流程严格，但需注意其混合OA模式可能涉及较高的版面费风险。总体而言，该期刊在药物化学领域具有一定影响力，适合相关领域的研究者投稿。

影响因子趋势

近期发表

Phthalazine as a medically versatile polyheterocyclic core with underexplored anticancer potential 2026-09-18

Statement of retraction 2026-09-16

New antifungal and less toxic zwitterionic derivatives of 26-membered polyene antibiotic – pimaricin containing N -benzyl and N -alkyl moieties and their molecular mechanism 2026-09-10

Exploring novel isatin derivatives as SARS-CoV-2 3CL pro inhibitors 2026-09-11

Cryo-EM structure-based discovery of etravirine as a specific inhibitor of PRMT5/pICln protein-protein interaction for prostate cancer treatment 2026-09-09

Design of aptamer peptides for immunomodulation 2026-09-02

Exploration of novel hydroxamic acid-based candidates integrating chalcone scaffold cap as multitarget HDAC inhibitors: design, anti-prostatic cancer assessment, in silico docking and molecular dynamic simulation 2026-08-28

Inhibition effects and binding interactions of epigallocatechin and gallocatechin on tyrosinase and their anti-melanogenesis activity 2026-08-26

Identification of a candidate PRODH allosteric inhibitor MBTP-15324: modulation of proline metabolite profiles and ECM-associated gene-expression changes in lung cancer cells 2026-08-24

Conformationally constrained 6‑aryl‑1‑(3,4,5‑trimethoxyphenyl)-1 H -pyrazolo[3,4‑b]pyrazines as novel microtubule destabilizers: design, synthesis, and antitumor evaluation 2026-08-20